ursodeoxycholic acid has been researched along with Hepatitis, Autoimmune in 120 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (7.50) | 18.2507 |
| 2000's | 53 (44.17) | 29.6817 |
| 2010's | 45 (37.50) | 24.3611 |
| 2020's | 13 (10.83) | 2.80 |
| Authors | Studies |
|---|---|
| Fujiwara, K; Katano, T; Kataoka, H; Matsuura, K; Nagura, Y; Naitoh, I; Nojiri, S; Suzuki, T | 1 |
| Hussain, N; Trivedi, PJ | 1 |
| Chen, H; Gao, X; Hong, X; Hu, S; Jin, X; Qiao, Z; Xia, C; Xiang, X; Xu, Y; Zhang, P | 1 |
| Ben Azouz, S; Boukriba, S; Cherif, D; Debbabi, H; Ghayeb, F; Hassine, H; Kchir, H; Maamouri, N; Yacoub, H | 1 |
| Guan, L; Li, X; Li, Y; Lin, X; Wang, N; Zhang, X | 1 |
| Shah, N; Yik, B | 1 |
| Enoki, Y; Hitomi, M; Inoue, N; Kawabata, H; Kawakatsu, Y; Minamikawa, T; Miyata, M; Motoi, S; Okazaki, Y; Sone, D; Ueda, Y; Yamaguchi, K | 1 |
| Castro Limo, JD; Romero-Gutiérrez, M; Ruiz Martín, J | 1 |
| Fan, X; Hu, Z; Men, R; Ni, P; Shen, Y; Wen, M; Yang, L | 1 |
| Bezerra, JA; de Carvalho, E; Gama, J; Porta, G; Santos, JL | 1 |
| Chen, L; Han, W; Jin, J; Li, W; Qu, L; Shi, X | 1 |
| Di Giorgio, A; Mieli-Vergani, G; Vergani, D | 1 |
| Xu, H; Yang, J; Yang, L; Yang, X | 1 |
| Jeong, SH | 1 |
| Jin, J; Yan, X | 1 |
| Gonzalez, RS; Washington, K | 1 |
| Díaz Ramírez, GS; Donado Gómez, JH; Marín Zuluaga, JI; Martínez Casas, OY; Muñoz Maya, O; Restrepo Gutiérrez, JC; Santos, Ó | 1 |
| Fan, X; Lu, C; Men, R; Shen, Y; Wen, M; Yang, L; Zhu, Y | 1 |
| Silveira, M; To, U | 1 |
| Ben Mansour, W; Bouhlel, W; Guediche, A; Jemmali, D; Loghmari, MH; Safer, L | 1 |
| Azzam, RK; Mataya, L; Patel, N | 1 |
| D'Adda, A; D'Antiga, L; Di Giorgio, A; Licini, L; Marseglia, A; Nicastro, E; Sonzogni, A | 1 |
| Amano, N; Genda, T; Harada, K; Iijima, K; Matsumoto, K; Murata, A; Sato, S; Shimada, Y; Tomishima, K; Tsuzura, H | 1 |
| Hagymási, K; Tulassay, Z | 1 |
| Imam, MH; Lindor, KD; Talwalkar, JA | 1 |
| Czaja, AJ | 2 |
| Bresson-Hadni, S; Efe, C; Heurgué-Berlot, A; Kav, T; Masi, C; Muratori, L; Muratori, P; Ozaslan, E; Purnak, T; Schiano, TD; Thiéfin, G; Ustündag, Y; Wahlin, S | 1 |
| Bahri, I; Boudawara, T; Gargouri, L; Maalej, B; Mahfoudh, A; Majdoub, I; Mnif, H; Mnif, L; Safi, F; Tahri, N; Turki, F | 1 |
| Bhamidimarri, KR; Giordano, C; Levy, C; Mandalia, A; Martin, P; Naik, J; O'Brien, C; Schiff, ER | 1 |
| Bresson-Hadni, S; Efe, C; Heurgué-Berlot, A; Kav, T; Masi, C; Muratori, L; Muratori, P; Ozaslan, E; Purnak, T; Schiano, TD; Thiéfin, G; Torgutalp, M; Wahlin, S | 1 |
| Lohse, AW; Zenouzi, R | 1 |
| Bunchorntavakul, C; Reddy, KR | 1 |
| Abudumijiti, H; Chen, K; Dai, W; Guo, C; Li, J; Li, S; Liu, T; Lu, J; Lu, W; Wang, C; Wang, F; Wang, J; Xia, Y; Yang, J; Zhang, H; Zheng, Y; Zhou, Y; Zhou, Z; Zhu, R | 1 |
| Kang, YZ; Liu, YH; Shen, ZY; Sun, XY | 1 |
| Cho, EJ; Cho, Y; Kim, YJ; Park, Y | 1 |
| Daa, T; Kan, M; Omori, K; Yokota, M; Yoshida, K | 1 |
| Abbas, Z; Abe, M; Amarapurkar, DN; Chang, ML; Efe, C; Han, KH; Kim, YJ; Ma, X; Mitchell-Thain, R; Ozaslan, E; Payawal, DA; Takikawa, H; Tanaka, A; Vierling, JM; Weltman, M; Yokosuka, O; You, H; Zeniya, M | 1 |
| Abe, M; Arinaga-Hino, T; Fujisawa, T; Kang, JH; Nakamoto, N; Ohira, H; Suzuki, Y; Takahashi, A; Takaki, A; Takikawa, H; Tanaka, A; Torimura, T; Yonemoto, K; Yoshizawa, K; Zeniya, M | 1 |
| Alawad, AS; Levy, C | 1 |
| Bhanji, RA; Mason, AL; Montano-Loza, AJ; Wasilenko, S | 1 |
| Endo, T; Fukuda, S; Igarashi, G; Kijima, H; Kurose, A; Mikami, K; Ohta, R; Sakamoto, J; Satake, R; Sawada, N; Yoshimura, T | 1 |
| Beuers, U; Rust, C | 2 |
| Dienes, HP; Frenzel, C; Galle, PR; Herkel, J; Kanzler, S; Kasper, HU; Lohse, AW; Lüth, S; Schramm, C | 1 |
| Imai, Y; Kajikawa, H; Kojima, Y; Kuchide, M; Matsushita, M; Matsuyama, K; Shimamoto, F; Takemura, T; Takimoto, K; Yamauchi, H; Yoshikawa, T | 1 |
| Lohse, AW; Lüth, S; Schramm, C; Weiler-Normann, C | 1 |
| Cullen, S; Maggs, J | 1 |
| Krok, KL; Munoz, SJ | 1 |
| Betterle, C; Bisconte, MG; Gentile, C; Gentile, M; Leo, P; Lucia, E; Mazzone, C; Morabito, F; Perugini, D; Romeo, F; Verta, M; Vigna, E | 1 |
| Abe, K; Honma, F; Kanno, Y; Monoe, K; Ohira, H; Saito, H; Sakamoto, N; Takahashi, A; Yokokawa, H; Yokokawa, J | 1 |
| Altiparmak, E; Efe, C; Nasiroglu, N; Ozaslan, E; Purnak, T; Tunca, H | 1 |
| Knight, C; Murray, KF | 1 |
| Lindor, KD; Zein, CO | 1 |
| Arulprakash, S; Bala, MR; Kumar, SJ; Pugazhendhi, T; Sasi, AD | 1 |
| Golovanova, EV; Khomeriki, SG; Petrakov, AV; Serova, TI | 1 |
| Altiparmak, E; Efe, C; Karaaslan, Y; Muratori, P; Ozaslan, E; Ozbalkan, Z; Purnak, T; Wahlin, S | 1 |
| Chapman, RW; Culver, EL | 1 |
| Murashima, N; Nakayama, S | 1 |
| Abe, M; Mashiba, T; Onji, M; Tsubouchi, H; Yamamoto, K; Zeniya, M | 1 |
| Han, Y; Han, ZY; Huang, XF; Jia, G; Li, ZS; Shi, YQ; Wang, JH; Wang, RA; Zhou, XM; Zhu, JY | 1 |
| Abe, K; Kanno, Y; Katsushima, F; Monoe, K; Ohira, H; Saito, H; Takahashi, A; Yokokawa, J | 1 |
| Casadio, C; Gaddoni, G; Giacomoni, P; Lanzanova, G; Maio, V; Patrizi, A; Savoia, F; Spadola, G; Tabanelli, M; Zago, S | 1 |
| Hino-Arinaga, T; Hisamochi, A; Ide, T; Kuromatsu, R; Kuwahara, R; Miyajima, I; Ogata, K; Sata, M; Torimura, T | 1 |
| Golovanova, EV | 1 |
| Bayat, A; Larsen, EP; Vyberg, M | 1 |
| Carey, EJ; Lindor, KD | 1 |
| Bugdaci, MS; Dagli, M; Karabagli, P; Korkmaz, H; Temel, T | 1 |
| Löhr, HF | 1 |
| Chazouillères, O; Poupon, R | 1 |
| Ben Ammar, A; Chaabouni, H; Cheikh, I; Ouerghi, H; Said, Y | 2 |
| Baragiotta, A; Floreani, A; Guido, M | 1 |
| Blickstein, I; Kruchkovich, J | 1 |
| Manns, MP; Strassburg, CP | 1 |
| Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C | 1 |
| Kayacetin, E; Köklü, S; Temuçin, T | 1 |
| Blum, HE; Kreisel, W; Opitz, OG; Thimme, R | 1 |
| Akimoto, T; Hirata, A; Kato, H; Miyashita, M; Nonaka, H; Saito, N; Saito, Y; Shinohara, M; Sugimoto, M; Wakui, T | 1 |
| Bueverov, AO | 1 |
| Geng, H; Han, YK; Zeng, Z; Zhang, XF | 1 |
| Ditelberg, J; Kaplan, MM; Vallone, TM | 1 |
| Hayashida, K; Kadokawa, Y; Kohno, S; Kusakari, C; Mizuta, Y; Murata, I; Nakanuma, Y; Ohba, K; Omagari, K; Takeshima, F | 1 |
| Lohse, AW; Schramm, C | 1 |
| Fukai, K; Imazeki, F; Kanda, T; Mikata, R; Saisho, H; Yokosuka, O | 1 |
| Baldo, V; Blasone, L; Carderi, I; Caroli, D; Ferrara, F; Floreani, A; Rizzotto, ER | 1 |
| Gordon, FD; Keaveny, AP; Khettry, U | 1 |
| Chazouillères, O; Poupon, R; Rosmorduc, O; Serfaty, L; Wendum, D | 1 |
| Ballot, E; Cadranel, JF; Cazier, A; Coutarel, P; Di Martino, V; Duclos-Vallée, JC; Emile, JF; Guettier, C; Johanet, C; Yamamoto, AM | 1 |
| Benderitter, T; Bourlière, M; Calvet, B; Halfon, P; Harafa, A; Igual, JP; Larroque, O; Martini, F; Ouzan, D; Penaranda, G; Renou, C; Sokolowsky, S | 1 |
| Bae, SH; Kim, DH; Kim, JS | 1 |
| Imamura, M; Ishida, H; Nakajima, H; Nezu, S; Takahashi, S; Tanaka, A; Yasui, H | 1 |
| Ikeda, H; Iwasaki, Y; Kobashi, H; Makino, Y; Miyake, Y; Okamaoto, R; Sakaguchi, K; Shiratori, Y; Takaguchi, K; Terada, R | 1 |
| Bernard-Chabert, B; Cadiot, G; Diebold, MD; Frémond, L; Geoffroy, P; Heurgué, A; Louvet, H; Pennaforte, JL; Picot, R; Schmit, JL; Thiéfin, G; Vitry, F; Yaziji, N | 1 |
| Angulo, P; Lindor, KD; Silveira, MG; Talwalkar, JA | 1 |
| Irisawa, A; Kanno, Y; Monoe, K; Ohira, H; Rai, T; Saito, H; Takahashi, A | 1 |
| Gershwin, ME; Ishibashi, H; Komori, A; Shimoda, S | 1 |
| Gossard, AA; Lindor, KD | 1 |
| Houwen, RH; Stapelbroek, JM; van de Nadort, C | 1 |
| Bianchi, L; Menges, M; Mueller, T | 1 |
| Pan, MH; Zhou, XJ | 1 |
| Al-Chalabi, T; Bernal, W; Heneghan, MA; McFarlane, IG; Portmann, BC | 1 |
| Gerken, G; Schlaak, JF | 1 |
| Heathcote, J | 1 |
| Aoshima, M; Aso, K; Hasegawa, T; Makino, I; Nakamura, K; Sato, Y; Tamori, K; Yokohama, S; Yoneda, M | 1 |
| Chazouillères, O; Montembault, S; Poupon, R; Rosmorduc, O; Serfaty, L; Wendum, D | 1 |
| Makino, I; Nakamura, K | 1 |
| Aoshima, M; Aso, K; Makino, I; Matui, T; Nakade, Y; Nakamura, K; Sato, Y; Takamoto, S; Tamori, K; Yokohama, S; Yoneda, M | 1 |
| Batts, KP; Gleich, GJ; Kephart, GM; Kita, H; Lindor, KD; Nakamura, A; Sato, S; Suzuki, K; Tarara, JE; Yamazaki, K | 1 |
| Carpenter, HA; Czaja, AJ; Lindor, KD | 1 |
| Toda, G; Zenia, M | 1 |
| Chang, FY; Co, RL; Hwang, SJ; Lee, SD; Li, CP; Luo, JC; Tong, MJ; Tsay, SH | 1 |
| Czaja, AJ; Lindor, KD | 1 |
| Del Soldato, P; Fiorucci, S; Ignarro, LJ; Mencarelli, A; Morelli, A; Palazzetti, B | 1 |
| Voigt, M; Weyman, RL | 1 |
| Koçak, N; Saltik, IN | 1 |
| Gish, RG; Mason, A | 1 |
| Gershwin, ME; Mitamura, K; Morizane, T; Onozuka, Y; Shibata, M; Tanaka, A; Uchida, T | 1 |
| Batts, K; Cauch-Dudek, K; Heathcote, EJ; Jorgensen, R; Joshi, S; Lindor, KD; Wanless, IR | 1 |
38 review(s) available for ursodeoxycholic acid and Hepatitis, Autoimmune
| Article | Year |
|---|---|
The Inconvenient Truth of Primary Biliary Cholangitis/Autoimmune Hepatitis Overlap Syndrome.
Topics: Disease Progression; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Syndrome; Ursodeoxycholic Acid | 2022 |
Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.
Topics: Adult; Cholangitis, Sclerosing; Colitis, Ulcerative; Connective Tissue Diseases; Hepatitis, Autoimmune; Humans; Liver Diseases; Male; Syndrome; Ursodeoxycholic Acid | 2023 |
Autoconversion of Autoimmune Liver Diseases.
Topics: Adult; Autoantibodies; Autoimmunity; Azathioprine; Biomarkers; Cholagogues and Choleretics; Diagnostic Errors; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Mitochondria; Predictive Value of Tests; Prednisone; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Cutting edge issues in juvenile sclerosing cholangitis.
Topics: Child; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Neoplasm Recurrence, Local; Ursodeoxycholic Acid | 2022 |
Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea.
Topics: Anti-Inflammatory Agents; Hepatitis, Autoimmune; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Prednisolone; Prevalence; Republic of Korea; Treatment Outcome; Ursodeoxycholic Acid | 2018 |
Primary Biliary Cholangitis and Autoimmune Hepatitis.
Topics: Biopsy; Cholangitis; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Prognosis; Ursodeoxycholic Acid | 2018 |
Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis.
Topics: Ascites; Cholagogues and Choleretics; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glucocorticoids; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Mortality; Ursodeoxycholic Acid | 2018 |
Autoimmune Liver Diseases in Children.
Topics: Adolescent; Child; Cholangitis, Sclerosing; Diagnosis, Differential; Endoscopy; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Transplantation; Ursodeoxycholic Acid | 2018 |
[Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties].
Topics: Adrenal Cortex Hormones; Autoantibodies; Autoimmunity; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Syndrome; Ursodeoxycholic Acid | 2013 |
Clinical management of autoimmune biliary diseases.
Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Outcome Assessment, Health Care; Prognosis; Ursodeoxycholic Acid | 2013 |
Diagnosis and management of the overlap syndromes of autoimmune hepatitis.
Topics: Adult; Alkaline Phosphatase; Cholangitis, Sclerosing; Cholestasis; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2013 |
Diagnosis and management of overlap syndromes.
Topics: Autoantibodies; Cholagogues and Choleretics; Cholangitis, Sclerosing; Diagnosis, Differential; Disease Progression; Hepatitis, Autoimmune; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Syndrome; Ursodeoxycholic Acid | 2015 |
Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
Topics: Budesonide; Chi-Square Distribution; Cholagogues and Choleretics; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Odds Ratio; Randomized Controlled Trials as Topic; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016.
Topics: Asia; Congresses as Topic; Disease Management; Female; Hepatitis, Autoimmune; Humans; Japan; Liver Cirrhosis, Biliary; Male; Taiwan; Ursodeoxycholic Acid | 2016 |
FXR Agonists: From Bench to Bedside, a Guide for Clinicians.
Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2016 |
Systematic review: recurrent autoimmune liver diseases after liver transplantation.
Topics: Adult; Clinical Trials as Topic; Cyclosporine; Female; Graft Survival; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Recurrence; Steroids; Survival Rate; Tacrolimus; Ursodeoxycholic Acid | 2017 |
Overlap syndromes among autoimmune liver diseases.
Topics: Adolescent; Adult; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2008 |
[Autoimmune liver diseases].
Topics: Cholagogues and Choleretics; Hepatitis, Autoimmune; Humans; Ursodeoxycholic Acid | 2009 |
Management of autoimmune liver disease.
Topics: Autoantibodies; Azathioprine; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangiocarcinoma; Clinical Trials as Topic; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Ursodeoxycholic Acid | 2009 |
The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Middle Aged; Scleroderma, Systemic; Sjogren's Syndrome; Ursodeoxycholic Acid | 2010 |
Hepatobiliary associations with inflammatory bowel disease.
Topics: Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Steroids; Ursodeoxycholic Acid | 2009 |
Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Clinical Protocols; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2010 |
Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.
Topics: Animals; Cholangitis, Sclerosing; Disease Progression; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Mice; Syndrome; Ursodeoxycholic Acid | 2011 |
Small duct autoimmune sclerosing cholangitis and Crohn colitis in a 10-year-old child. A case report and review of the literature.
Topics: Bile Ducts; Biomarkers; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Colitis; Colonoscopy; Crohn Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Predictive Value of Tests; Severity of Illness Index; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Current pharmacotherapy for cholestatic liver disease.
Topics: Cholangitis, Sclerosing; Cholestasis; Fibric Acids; Hepatitis, Autoimmune; Humans; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2012 |
[Autoimmune hepatitis and overlap syndrome: therapy].
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Haplotypes; Hepatitis, Autoimmune; HLA Antigens; Humans; Liver Cirrhosis, Biliary; Prednisolone; Syndrome; Ursodeoxycholic Acid | 2002 |
Treatment strategies in autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Clinical Trials as Topic; Cyclosporine; Disease Progression; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
[Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy].
Topics: Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Hepatitis, Autoimmune; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Mitochondria, Liver; Prognosis; Syndrome; Ursodeoxycholic Acid | 2004 |
[Autoimmune liver disease: diagnosis and therapy].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Immunoassay; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prognosis; Ultrasonography; Ursodeoxycholic Acid | 2004 |
[Cholestatic liver diseases].
Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid | 2004 |
Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Puerperal Disorders; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.
Topics: Autoantibodies; Cholagogues and Choleretics; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Prevalence; Ursodeoxycholic Acid | 2005 |
Overlap syndromes.
Topics: Adult; Age of Onset; Aged; Cholagogues and Choleretics; Cholangitis, Sclerosing; Comorbidity; Diagnosis, Differential; Disease Progression; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Failure; Male; Prognosis; Syndrome; Ursodeoxycholic Acid | 2005 |
[Pathologic diagnosis of autoimmune liver disease].
Topics: Autoimmune Diseases; Cholangitis; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Interferon-gamma; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2007 |
[Autoimmune hepatitis: progress in its treatment].
Topics: Azathioprine; Female; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Middle Aged; Prednisolone; Ursodeoxycholic Acid | 1999 |
[Recent progress in the diagnosis and therapy of autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Prednisolone; Ursodeoxycholic Acid | 1999 |
Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature.
Topics: Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Recurrence; Ursodeoxycholic Acid | 2001 |
Autoimmune liver disease. Current standards, future directions.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Prednisone; Prognosis; Ursodeoxycholic Acid | 2001 |
7 trial(s) available for ursodeoxycholic acid and Hepatitis, Autoimmune
| Article | Year |
|---|---|
[Observation on therapeutic alliance with UDCA and glucocorticoids in AIH-PBC overlap syndrome].
Topics: Adult; Alanine Transaminase; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis.
Topics: Aged; Alanine Transaminase; Aspartate Aminotransferases; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Japan; Liver; Male; Middle Aged; Pilot Projects; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C.
Topics: Alanine Transaminase; Biomarkers; Female; Fluorescent Antibody Technique, Indirect; Hepatitis C, Chronic; Hepatitis, Autoimmune; Humans; Liver Function Tests; Male; Middle Aged; Prospective Studies; Time Factors; Ursodeoxycholic Acid | 1999 |
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis.
Topics: Blood Proteins; Cell Degranulation; Cholestasis; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Eosinophils; Female; Hepatitis, Autoimmune; Hepatitis, Viral, Human; Humans; Immunohistochemistry; Leukocyte Count; Liver; Liver Cirrhosis, Biliary; Male; Placebos; Proteins; Radioimmunoassay; Ribonucleases; Ursodeoxycholic Acid | 1999 |
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Double-Blind Method; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Placebos; Prednisone; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Bone Density; Budesonide; Female; Femur; Hepatitis, Autoimmune; Humans; Male; Middle Aged; Pilot Projects; Prednisone; Retreatment; Spine; Treatment Failure; Ursodeoxycholic Acid | 2000 |
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.
Topics: Adult; Antibodies, Antinuclear; Biopsy; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Survival Analysis; Ursodeoxycholic Acid | 2002 |
75 other study(ies) available for ursodeoxycholic acid and Hepatitis, Autoimmune
| Article | Year |
|---|---|
Primary Sclerosing Cholangitis and Autoimmune Hepatitis Overlapping Syndrome Complicated by Ulcerative Colitis.
Topics: Adult; Biopsy; Cholangitis, Sclerosing; Colitis, Ulcerative; Connective Tissue Diseases; Hepatitis, Autoimmune; Humans; Male; Syndrome; Ursodeoxycholic Acid | 2022 |
Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report.
Topics: Azathioprine; Glomerulonephritis, Membranous; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2023 |
Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports.
Topics: Cholangitis, Sclerosing; Connective Tissue Diseases; Constriction, Pathologic; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Syndrome; Ursodeoxycholic Acid | 2023 |
IgG4-related Autoimmune Hepatitis with a Suspected Drug-induced Etiology.
Topics: Aged; Anti-Inflammatory Agents; Cholagogues and Choleretics; Hepatitis, Autoimmune; Hepatitis, Chronic; Humans; Immunoglobulin G; Japan; Male; Nifedipine; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Effective treatment of autoimmune hepatitis-primary biliary cholangitis overlap syndrome with obeticholic acid.
Topics: Adult; Chenodeoxycholic Acid; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2020 |
Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features.
Topics: Adult; Cholagogues and Choleretics; Drug Monitoring; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 2021 |
Autoimmune Hepatitis: Predictors of Native Liver Survival in Children and Adolescents.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Complement C3; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Infant; International Normalized Ratio; Leukocyte Count; Liver Transplantation; Male; Platelet Count; Remission Induction; Serum Albumin; Ursodeoxycholic Acid | 2021 |
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome in a patient with paroxysmal nocturnal hemoglobinuria: a case report.
Topics: Adult; Female; Hemoglobinuria, Paroxysmal; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Prednisolone; Ursodeoxycholic Acid | 2021 |
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.
Topics: Azathioprine; Bone Marrow Diseases; Cholangitis, Sclerosing; Ethnicity; Genetic Predisposition to Disease; Genotype; Hepatitis, Autoimmune; Humans; Male; Methyltransferases; Middle Aged; Polymorphism, Single Nucleotide; Prednisolone; Pyrophosphatases; Ursodeoxycholic Acid | 2017 |
Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report.
Topics: Amyloidosis, Familial; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Sjogren's Syndrome; Skin Diseases, Genetic; Treatment Outcome; Undifferentiated Connective Tissue Diseases; Ursodeoxycholic Acid | 2018 |
Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Topics: Adrenal Cortex Hormones; Adult; Colombia; Disease Progression; Female; Follow-Up Studies; Hepatitis, Autoimmune; Hospitals, University; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Syndrome; Ursodeoxycholic Acid | 2018 |
Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study.
Topics: Adult; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Image-Guided Biopsy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Treatment Outcome; Undifferentiated Connective Tissue Diseases; Ursodeoxycholic Acid | 2018 |
Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2018 |
Biliary features in liver histology of children with autoimmune liver disease.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Lymphocytes; Male; Prednisone; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Cholagogues and Choleretics; Cholestasis; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunoglobulin M; Liver Cirrhosis, Biliary; Mitochondrial Proteins; Prednisolone; Ursodeoxycholic Acid | 2020 |
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholagogues and Choleretics; Cohort Studies; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2014 |
Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy.
Topics: Alkaline Phosphatase; Azathioprine; Biomarkers; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; gamma-Globulins; gamma-Glutamyltransferase; Glucocorticoids; Hepatitis, Autoimmune; Hepatomegaly; Humans; Immunosuppressive Agents; Jaundice; Magnetic Resonance Imaging; Male; Prednisone; Splenomegaly; Transaminases; Treatment Outcome; Ursodeoxycholic Acid | 2013 |
Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics.
Topics: Adolescent; Adult; Aged; Cholagogues and Choleretics; Cross-Sectional Studies; Ethnicity; Female; Hepatitis, Autoimmune; Hispanic or Latino; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2014 |
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Biomarkers; Disease Progression; Drug Therapy, Combination; Europe; Female; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Remission Induction; Retrospective Studies; Risk Factors; Syndrome; Time Factors; Treatment Outcome; United States; Ursodeoxycholic Acid; Young Adult | 2014 |
Long-term outcome in PSC/AIH "overlap syndrome": does immunosuppression also treat the PSC component?
Topics: Adult; Cholangitis, Sclerosing; Disease Progression; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Liver Transplantation; Male; Middle Aged; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation.
Topics: Cholagogues and Choleretics; Cholestasis; Fatty Liver, Alcoholic; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prednisone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.
Topics: Adult; Aged; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Republic of Korea; Retrospective Studies; Steroids; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
Familial occurrence of autoimmune liver disease with overlapping features of primary biliary cholangitis and autoimmune hepatitis in a mother and her daughter.
Topics: Aged; Biopsy; Cholagogues and Choleretics; Cholangitis; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver; Middle Aged; Prednisolone; Ursodeoxycholic Acid | 2016 |
Autoimmune hepatitis in Japan: trends in a nationwide survey.
Topics: Acute Disease; Adult; Age Distribution; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Health Care Surveys; Health Surveys; Hepatitis, Autoimmune; Hepatitis, Chronic; Humans; Japan; Liver; Male; Middle Aged; Prednisolone; Professional Practice; Ursodeoxycholic Acid; Young Adult | 2017 |
Two Cases of Primary Sclerosing Cholangitis Overlapping with Autoimmune Hepatitis in Adults.
Topics: Biopsy; Cholangiography; Cholangitis, Sclerosing; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver; Male; Middle Aged; Syndrome; Tomography, X-Ray Computed; Ursodeoxycholic Acid; Young Adult | 2017 |
[Infrequent but serious: autoimmune hepatitis and primary biliary cirrhosis. Early therapy improves long-term prognosis].
Topics: Budesonide; Drug Therapy, Combination; Hepatitis, Autoimmune; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Long-Term Care; Prognosis; Ursodeoxycholic Acid | 2008 |
Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
Topics: Adolescent; Adult; Aged; Cholangiography; Cholangitis, Sclerosing; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Male; Middle Aged; Prognosis; Retrospective Studies; Syndrome; Ursodeoxycholic Acid; Young Adult | 2009 |
[A case of probable autoimmune hepatitis from which the persistence of hepatitis A IgM antibody, and the improvement was pathologically obtained by ursodeoxycholic acid medication].
Topics: Aged; Cholagogues and Choleretics; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Immunoglobulin M; Ursodeoxycholic Acid | 2008 |
Management of autoimmune and cholestatic liver disorders.
Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis, Sclerosing; Chronic Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Transplantation; Practice Guidelines as Topic; Prednisone; Ursodeoxycholic Acid | 2009 |
Autoimmune hemolityc anemia concomitant with sequential autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Hashimoto's thyroiditis: a new entity of autoimmune polyendocrine syndrome.
Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Budesonide; Female; Hashimoto Disease; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Polyendocrinopathies, Autoimmune; Syndrome; Ursodeoxycholic Acid | 2009 |
Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
Topics: Alanine Transaminase; Alkaline Phosphatase; Biomarkers; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Prednisolone; Retrospective Studies; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
Topics: Adult; Autoantibodies; Biopsy; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
[Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid | 2010 |
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases.
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Hydroxychloroquine; Immunoblotting; Immunoglobulin G; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2011 |
Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis triggered by fluvastatin.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Anticholesteremic Agents; Autoantibodies; Coronary Artery Disease; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Hepatitis, Autoimmune; Humans; Indoles; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Prednisone; Ursodeoxycholic Acid | 2011 |
Present status of autoimmune hepatitis in Japan: a nationwide survey.
Topics: Acute Disease; Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Glucocorticoids; Health Surveys; Hepatitis; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Infant; Japan; Male; Middle Aged; Ursodeoxycholic Acid; Young Adult | 2011 |
Case of primary biliary cirrhosis-autoimmune hepatitis overlap which manifested after delivery.
Topics: Adult; Bezafibrate; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Postpartum Period; Pregnancy; Ursodeoxycholic Acid | 2011 |
Prurigo nodularis as the first manifestation of a chronic autoimmune cholestatic hepatitis.
Topics: Alkaline Phosphatase; Antibodies, Antinuclear; Azathioprine; Cholestasis; Cyclosporine; Dermatologic Agents; Female; gamma-Glutamyltransferase; Hepatitis, Autoimmune; Humans; Middle Aged; Prurigo; Ursodeoxycholic Acid | 2011 |
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Topics: Aged; Alanine Transaminase; Azathioprine; Biomarkers; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Prednisolone; Retrospective Studies; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
[3rd place in the competition of scientific work in hepatology in 2010. Treatment of patients with overlap of primary biliary cirrhosis and autoimmune hepatitis].
Topics: Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Prednisolone; Quality of Life; Surveys and Questionnaires; Ursodeoxycholic Acid | 2011 |
Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome).
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Antinuclear; Autoantibodies; Cholagogues and Choleretics; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulins, Intravenous; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria, Liver; Prednisolone; Thrombocytopenia; Ursodeoxycholic Acid | 2013 |
Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis.
Topics: Cholagogues and Choleretics; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2002 |
[Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients].
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Time Factors; Ursodeoxycholic Acid | 2003 |
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment.
Topics: Adult; Cholagogues and Choleretics; Drug Resistance; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Syndrome; Ursodeoxycholic Acid | 2003 |
[Autoimmune hepatitis during pregnancy].
Topics: Adult; Autoantibodies; Azathioprine; Budesonide; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Obstetric Labor Complications; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Ursodeoxycholic Acid | 2003 |
[The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases].
Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Cholagogues and Choleretics; Clinical Enzyme Tests; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Retrospective Studies; Syndrome; Time Factors; Ursodeoxycholic Acid | 2003 |
Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure.
Topics: Cholagogues and Choleretics; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Failure; Middle Aged; Prednisolone; Ursodeoxycholic Acid | 2004 |
[A case of autoimmune hepatitis followed-up with an oral administration of ursodeoxycholic acid].
Topics: Administration, Oral; Aged; Cholagogues and Choleretics; Drug Administration Schedule; Female; Hepatitis, Autoimmune; Humans; Ursodeoxycholic Acid | 2004 |
[Treatment of autoimmune hepatic diseases].
Topics: Adult; Autoimmune Diseases; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Prognosis; Risk Factors; Syndrome; Time Factors; Ursodeoxycholic Acid | 2004 |
[Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome].
Topics: Adult; Autoantibodies; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 2005 |
Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Topics: Cholagogues and Choleretics; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Prednisone; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Prolonged acute hepatitis A mimicking autoimmune hepatitis.
Topics: Acute Disease; Antibodies, Antinuclear; Cholagogues and Choleretics; Diagnosis, Differential; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Middle Aged; Ursodeoxycholic Acid | 2005 |
Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome.
Topics: Adolescent; Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Male; Prospective Studies; Survival Analysis; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Post-liver transplantation de novo hepatitis with overlap features.
Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cholagogues and Choleretics; Drug Resistance; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
Topics: Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Deflazacort for type-1 autoimmune hepatitis in a Korean girl.
Topics: Child; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Korea; Pregnenediones; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis.
Topics: Animals; Anti-Inflammatory Agents; Autoantibodies; Bile Ducts; Cattle; Cholagogues and Choleretics; Female; Fibrosis; Hepatitis, Autoimmune; Humans; Liver; Male; Middle Aged; Mitochondria, Heart; Prednisolone; Ursodeoxycholic Acid | 2006 |
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prospective Studies; Recurrence; Treatment Outcome; Ursodeoxycholic Acid | 2006 |
Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; France; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Medical Records; Middle Aged; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.
Topics: Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Syndrome; Ursodeoxycholic Acid | 2007 |
Clinicolaboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap.
Topics: Adult; Aged; Alanine Transaminase; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid | 2006 |
Guidelines for therapy of autoimmune liver disease.
Topics: Animals; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Practice Guidelines as Topic; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
Development of autoimmune hepatitis in primary biliary cirrhosis.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Ursodeoxycholic Acid | 2007 |
Re: Azathioprine monotherapy for maintenance of remission in pediatric patients with autoimmune hepatitis.
Topics: Adolescent; Adrenal Cortex Hormones; Azathioprine; Child; Cholagogues and Choleretics; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Remission Induction; Ursodeoxycholic Acid | 2007 |
Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.
Topics: Adolescent; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Syndrome; Ursodeoxycholic Acid | 2008 |
Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Ursodeoxycholic Acid | 2008 |
[Chronic hepatitis. 7: Therapy of autoimmune liver diseases].
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Prednisone; Ursodeoxycholic Acid | 1997 |
Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis.
Topics: Animals; Female; Hepatitis, Autoimmune; Humans; Japan; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Syndrome; Treatment Outcome; Ursodeoxycholic Acid | 1998 |
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.
Topics: Adult; Antibodies, Antinuclear; Autoimmune Diseases; Biopsy; Cholagogues and Choleretics; Cholangitis; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Transaminases; Ursodeoxycholic Acid | 2000 |
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity.
Topics: Animals; Base Sequence; Caspase Inhibitors; Cysteine Proteinase Inhibitors; Cytokines; DNA Primers; Down-Regulation; Fas Ligand Protein; Hepatitis, Autoimmune; Humans; Liver; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Nitrates; RNA, Messenger; Salicylates; Tumor Cells, Cultured; Ursodeoxycholic Acid | 2001 |
The effect of ursodeoxycholic acid in children with prolonged hepatitis A virus infection that may be a trigger factor for autoimmune hepatitis.
Topics: Adolescent; Child; Cholagogues and Choleretics; Hepatitis A; Hepatitis, Autoimmune; Humans; Male; Ursodeoxycholic Acid | 2001 |
A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal gamma-globulinemia.
Topics: Aged; Autoantibodies; Cholagogues and Choleretics; Female; gamma-Globulins; Glucocorticoids; Hepatitis, Autoimmune; Hepatitis, Chronic; Humans; Mitochondria; Prednisolone; Ursodeoxycholic Acid | 2001 |